RNA Bioclin SRL
RNA Bioclin reported total assets of 305,062 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of RNA Bioclin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +307 % Total assets +119 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
RNA Bioclin's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 90,311 € | ||||
| Equity | 175,530 € | ||||
| Cash | 211,222 € | ||||
| EBITDA | 116,203 € | ||||
| Total assets | 305,062 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 08 Nov 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
RNA Bioclin's financial analysis
- Solvency57.5%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of RNA Bioclin
RNA Bioclin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0628.720.544
- VAT number
- BE0628720544
- Peppol
- Registered · 0208:0628720544 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Apr 2015
- Registered office
- 7020 Mons
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Medical specialists activities (NACE 86220)
RNA Bioclin (SRL) has been based in Mons since 2015, active in: medical specialists activities. For 2025, it reports a net profit of 90,311 € and equity of 175,530 €; its revenue is not published. Its solvency stands at 57.5%, below the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to RNA Bioclin
Companies in the same business, of comparable size and area, outside its group.
- Dokter S.K.C. Goossens Medical specialists activities Brasschaat · balance sheet 305,949 €
- Apades Medical specialists activities Namur · balance sheet 302,994 €
- Bleugimed Medical specialists activities Tournai · balance sheet 307,223 €
- Oftalmed Medical specialists activities Sint-Truiden · balance sheet 305,055 €
- Dr. Tache Medical specialists activities Edegem · balance sheet 305,086 €
- Pneumomedic Medical specialists activities Andenne · balance sheet 305,024 €
- Nyssen-Dehaye Medical specialists activities Ciney · balance sheet 304,959 €
- Dr. De Cocker Jeroen, Cardiologie Medical specialists activities Sint-Niklaas · balance sheet 304,907 €
Frequently asked questions about RNA Bioclin
What is the revenue of RNA Bioclin?
RNA Bioclin files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of RNA Bioclin?
In Belgium, the VAT number is the company number prefixed with BE: BE0628720544 for RNA Bioclin, if the company is VAT-registered. Its company number (CBE) is 0628.720.544.
Where is the registered office of RNA Bioclin?
According to the CBE register, the registered office of RNA Bioclin is in 7020 Mons.
What is the equity of RNA Bioclin?
At the close of the 2025 financial year, the equity of RNA Bioclin amounts to 175,530 €, a solvency of 57.5% of total assets.
Who manages RNA Bioclin?
The register lists 1 active mandates at RNA Bioclin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of RNA Bioclin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →